Navigation Links
Bausch + Lomb designa a Robert Bertolini presidente y CFO
Date:2/26/2013

nivel", dijo Bertolini. "Tenemos la urgente oportunidad de realizar la visión de Bausch + Lomb de convertirse en la mejor compañía global dedicada a la salud visual, para nuestros clientes y los pacientes que ellos atienden. Estoy entusiasmado y me siento honrado de formar parte de este equipo".

Anteriormente, el Sr. Bertolini fue vicepresidente ejecutivo y CFO en Schering-Plough Corporation, desde 2003 y hasta su fusión con Merck & Co. en 2009. Durante su mandato, Bertolini trabajó como socio comercial con el CEO en todos los aspectos relacionados con transformar las operaciones de la compañía. Era responsable de las principales áreas financieras, entre ellas impuestos, contabilidad y administración de activos financieros; forjó funciones de primer nivel relacionadas con finanzas y tecnologías de la información; y lideró el desarrollo y la estrategia comerciales.

Previamente en su carrera, Bertolini pasó 20 años en PricewaterhouseCoopers LLP, donde ocupó cargos de creciente responsabilidad y, finalmente, se convirtió en socio y lideró la especialidad en Industria Farmacéutica Global. Como tal, Bertolini fue asesor sénior del personal directivo superior en algunas de las compañías más conocidas relacionadas con el cuidado de la salud, sobre cuestiones financieras y comerciales generales, entre ellas acuerdos de licencias, operaciones de fusiones y adquisiciones, ofertas públicas iniciales (IPO, por sus siglas en inglés), alianzas estratégicas, auditoría, controles financieros y gobernanza corporativa.

Bertolini obtuvo su licenciatura en economía en Rutgers, la Universidad Pública de Nueva Jersey , y es Certified Public Accountant (Contador Público Certificado). Actualmente, es miembro del directorio de Actelion Pharmaceuticals y de Charle
'/>"/>

SOURCE Bausch + Lomb
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Bausch + Lomb Names John Barr Global President Surgical
2. Bausch + Lomb Completes the Acquisition of ISTA Pharmaceuticals
3. Bausch + Lomb Commences Tender Offer of Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3 and U07190AA6)
4. Bausch + Lomb Announces Extension of Early Tender Date for Its Previously Announced Tender Offer for Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3, U07190AA6 and 071707AP8)
5. Bausch + Lomb Announces Final Results for Its Previously Announced Tender Offer for Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3, U07190AA6 and 071707AP8)
6. Bausch + Lomb Product, Platform and Pipeline Innovations on Display at the Annual Meeting of the American Academy of Ophthalmology
7. Bausch + Lomb und CROMA spenden dringend benötigte Augentropfen
8. Bausch + Lomb Names Robert Bertolini President And Chief Financial Officer
9. Bausch + Lomb nomme Robert Bertolini président et directeur financier
10. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
11. CSL Behring Receives FDA Orphan Drug Designation for rIX-FP, a Novel Therapy in Development to Treat Congenital Factor IX Deficiency (Hemophilia B)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ATLANTA , June 30, 2015 Legal-Bay ... the first bellwether trial in the multidistrict litigation (MDL) ... scheduled to begin October 13 th , 2015. There ... Inc. which have been consolidated before a federal judge ... that the first bellwether trial will begin in October ...
(Date:6/29/2015)... June 29, 2015  New guidelines released today ... Association give hope for better outcomes to the ... acute ischemic stroke each year. Stryker,s Trevo ® ... used in the clinical trials that provided data ... guidelines strongly recommend endovascular therapy with stent retrievers ...
(Date:6/29/2015)... -- Allergan plc (NYSE: AGN ) today announced ... financial results on Thursday, August 6, 2015, prior ... Company will host a conference call and webcast ... August 6, 2015 to discuss its financial results. The ... Canada (877) 251-7980, International (706) ...
Breaking Medicine Technology:Legal-Bay Lawsuit Settlement Funding Reports Zimmer NexGen Knee Bellwether Trial to Begin October 13th, 2015 2Legal-Bay Lawsuit Settlement Funding Reports Zimmer NexGen Knee Bellwether Trial to Begin October 13th, 2015 3New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 2New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 3Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 2Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 3
... Dyadic International, Inc. ("Dyadic") (OTC Pink: DYAI), ... development, manufacture and sale of enzyme and protein ... industries, today announced financial results for the quarter ... in this press release should be read in ...
... Southern Home Medical Equipment, Inc. (PINKSHEETS: SHOM), a ... equipment to medical institutions, announced today that Encore ... significant growth from Encore Medical Staffing operations in ... started this franchise in December, 2010," says Dr. ...
Cached Medicine Technology:Dyadic International Reports 2011 First Quarter Financial Results 2Dyadic International Reports 2011 First Quarter Financial Results 3Dyadic International Reports 2011 First Quarter Financial Results 4Dyadic International Reports 2011 First Quarter Financial Results 5Southern Home Medical Equipment Reports Significant Growth from Encore Franchisees 2
(Date:6/30/2015)... ... June 30, 2015 , ... ... drug response profiling test to help oncologists provide personalized cancer treatment, will ... CorrectChemo® assay provides the oncologist with valuable insight on how a specific ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... Center, has joined Allegheny Health Network (AHN) as Director of its ... the management of primary brain tumors, brain metastases, leptomeningeal disease and the neurological ...
(Date:6/30/2015)... ... June 30, 2015 , ... Harbor Village Detox ... addiction care in Florida on June 12th. Holly Vasquez-Cortella was recently quoted as ... a website dedicated to reporting on trending addiction news and treatment innovations. The article ...
(Date:6/30/2015)... ... 2015 , ... Under Armour’s new baselayer for football players—Gameday ... other padding in football. , Developed in partnership with D3O®, a leading UK-based ... engineered with D3O protective polymer. This radical polymer material has a unique molecular ...
(Date:6/30/2015)... ... June 30, 2015 , ... It has become fairly common to purchase fresh ... discard the stalks before cooking. Throwing out radish greens, beet leaves and chard stalks ... delicious. It just takes a little knowledge and practice to use them. Josie's ...
Breaking Medicine News(10 mins):Health News:Correct Chemo Joins NextGxDx Online Genetic Testing Marketplace 2Health News:Correct Chemo Joins NextGxDx Online Genetic Testing Marketplace 3Health News:Noted Duke Brain Cancer Specialist to Direct Allegheny Health Network Neuro-Oncology Program 2Health News:Noted Duke Brain Cancer Specialist to Direct Allegheny Health Network Neuro-Oncology Program 3Health News:Harbor Village Detox’s Clinical Director Is Quoted as an Addiction Expert by The Fix 2Health News:Harbor Village Detox’s Clinical Director Is Quoted as an Addiction Expert by The Fix 3Health News:Under Armour Launches Advanced Gameday Armour® Max Protection System For The Gridiron 2Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 2Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 3Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 4
... patients, research suggests , , SUNDAY, Nov. 4 (HealthDay News) ... who typically need open-heart surgery might someday have a ... valve. , The balloon is inserted percutaneously (through the ... experts said. In a new study, the procedure -- ...
... investigational compound; will include 10,000 medically managed patients ... ... A large Phase,III clinical trial is anticipated to begin ... prasugrel, an investigational oral antiplatelet,agent, against clopidogrel (Plavix(R)/Iscover(R)) in medically ...
... business from union benefit funds,Union coalition says Rite Aid wants union money, ... ... rights They are telling conference attendees: Trust Rite Aid? Think Twice!, ... old pharmacy benefits management company (Rite Aid,Solutions) at the International Foundation Employee ...
... journals planned for 2008, ORLANDO, Fl., Nov. 3 ... a part of Wolters Kluwer,Health, will launch six new ... subspecialty areas in cardiology., The new journals are ... the American Heart Association, which is ranked,first in the ...
... , FRIDAY, Nov. 2 (HealthDay News) -- As many ... United States because emergency departments across the country aren,t ... patients, according to a Johns Hopkins study. , ... heart attack and 3,955 pneumonia patients treated at 544 ...
... as 238 runners with 33 corporate teams compete in ... speed, size, and spirit categories this Sunday, SAN ... announced today that the field for the third,annual Comerica Corporate ... teams competing. (Logo: http://www.newscom.com/cgi-bin/prnh/20010807/CMALOGO ) The ...
Cached Medicine News:Health News:Balloon Valve May Be Alternative to Open-Heart Surgery 2Health News:Balloon Valve May Be Alternative to Open-Heart Surgery 3Health News:Daiichi Sankyo, Lilly Announce New Prasugrel Head-to-Head Phase III Study Against Clopidogrel 2Health News:Daiichi Sankyo, Lilly Announce New Prasugrel Head-to-Head Phase III Study Against Clopidogrel 3Health News:Daiichi Sankyo, Lilly Announce New Prasugrel Head-to-Head Phase III Study Against Clopidogrel 4Health News:Rite Aid's Fledgling Benefits Management Firm Hits Turbulence at Employee Benefits Conference in Anaheim 2Health News:News from Circulation: Journal of the American Heart Association 2Health News:News from Circulation: Journal of the American Heart Association 3Health News:News from Circulation: Journal of the American Heart Association 4Health News:Emergency Care for Heart Attacks, Pneumonia Fails to Meet Goals 2Health News:Biggest Field Ever to Compete Nov. 4 for 'Fastest Company in Silicon Valley' Title in the Comerica Corporate Challenge at The 2007 Metro Silicon Valley Marathon(R) 2Health News:Biggest Field Ever to Compete Nov. 4 for 'Fastest Company in Silicon Valley' Title in the Comerica Corporate Challenge at The 2007 Metro Silicon Valley Marathon(R) 3
... factor I (IGF-I or somatomedin C) is a ... It acts as a potent mitogen of cellular ... cell-surface receptors. In the circulation, IGF-I is bound ... the actions of IGF-I by modulating the interaction ...
... somatomedin C) is a 7.6 kDa peptide produced ... potent mitogen of cellular proliferation, exerting its actions ... circulation, IGF-I is bound to IGF-binding proteins (IGFBPs), ... by modulating the interaction of IGF-I with the ...
The Bard Ellik Bladder Evacuator is designed for ease of maneuverability during the removal of tissue sections during transurethral prostatectomy, TURPs, bladder biopsy, etc....
Image Diagnostics' Aspect100U is specifically designed for ease of use and high quality image outcome during urological procedures. Aspect tables benefit from a trim, lightweight design, ensuring a s...
Medicine Products: